In this webinar, experts in lung cancer from around the globe discuss the latest advancements in lung cancer treatment. Watch the webinar recording to get updates on treatment options for resectable NSCLC, thoracic surgery, and neoadjuvant immunotherapy for NSCLC.

You are viewing an International Congress run by Roche and provided to international HCPs from around the world. Please note that prescribing information provided here may vary depending on local approval in each country. For purposes of Global Talk, best efforts were undertaken by Roche to ensure compliance with the applicable law and regulations, however, you should review your local prescribing information and consult directly the local affiliate of the relevant Company to address any questions.

While cervical cancer is preventable, an estimated 14,000 new cases are diagnosed in the United States every year, leading to almost 4,300 deaths from the disease.

In this recording from the 21st International Congress of Cytology (ICC), Prof Mark Stoler shows evidence that the use of HPV DNA tests as the primary form of screening, followed by using p16/Ki-67 dual staining in triage can prove effective in identifying women who are at the highest risk of cervical cancer. This testing method gives actionable results that allows clinicians and health systems to prioritise resources for those who are in need of them.

The World Health Organisation recommends HPV self-sampling to ease emotional and psychological barriers that prevent many women from pursuing screening, thus empowering women to choose the approach that works best for them. Following WHO’s recommendations, Dr Gino Venegas, while serving as Director of Cancer at the Ministry of Health in 2017, developed the National Cervical Cancer plan and implemented a HPV primary screening program. To help achieve a target of 70% screening coverage, Peru dedicated substantial resources to public education and setting up HPV testing facilities in primary care settings in both urban and rural areas.

In this recording from IPVC 2023, Dr Gino Venegas shares how Peru tackled cervical cancer by addressing numerous barriers to screening, such as lack of awareness, affordability challenges, and social stigma around HPV testing.